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PURPOSE. The immediate early gene Egr-1 is thought to form part of the pathway that mediates
abnormal ocular growth. This study investigated whether the mRNA expression levels of Egr-
1 in a mammalian retina are modulated differentially, depending on the direction of ocular
growth.
METHODS. To induce accelerated growth and myopia, guinea pigs wore a 5 diopter (D) lens
over one eye from 4 to 11 days of age. To induce inhibited growth, the lens was removed after
7 days of 5 D lens wear, and the eye allowed to recover from myopia for 3 days. Ocular
parameters and Egr-1 mRNA levels were subsequently assessed, and compared to untreated
fellow eyes and eyes from untreated littermates. Possible circadian changes in Egr-1 mRNA
levels were also determined in 18 additional animals by taking measures every 4 hours during
a 24-hour cycle.
RESULTS. Ocular compensation to a 5 D lens occurred after 7 days (D 4.8 D, D þ147 lm
growth, N ¼ 20). In 5 highly myopic eyes (D 7.4 D), Egr-1 mRNA levels in the retina were
significantly downregulated relative to contralateral control (51%) and age-matched untreated
(47%) eyes. Three days after the 5 D lens was removed, eyes had recovered from the myopia
(D 0.5 D, relative change of þ2.9 D, N ¼ 4) and Egr-1 mRNA levels were significantly
elevated relative to contralateral (212%) and untreated (234%) eyes, respectively. Normal Egr-
1 mRNA expression was higher in the middle of the day than in the middle of the night.
Immunolabeling showed strong Egr-1 reactivity in cell bodies in the inner nuclear and
ganglion cell layers.
CONCLUSIONS. Egr-1 mRNA levels in a mammalian retina show a bi-directional persistent
response to opposing ocular growth stimuli. This suggests retinal Egr-1 might act as a signal
for the direction of ocular growth in different species.
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Myopia is an ocular disorder brought about by a mismatchbetween the axial length of the eye and its optical
properties, and commonly arises from excessive ocular
elongation during development. Research into possible optical
and pharmacologic treatments for the prevention of myopia has
been aided by the discovery that the rate of eye growth can be
manipulated experimentally in animals by altering their visual
experience during development.1,2 Myopia can be reliably
induced in young growing eyes by either form deprivation3–7
(FDM) or by imposing hyperopic defocus with a negative
lens8–13 (lens-induced myopia, LIM), both of which induce
excessive elongation of the eye. In humans, degradation of the
retinal image during ocular development through drooping
eyelids (ptosis)14 or cataracts15 may also result in myopia. In
contrast, inhibition of ocular growth occurs when the eye is
allowed to recover from the myopia induced during FDM or
LIM, by the subsequent removal of the diffuser or negative
lens,3,7 and when young animals wear a positive lens.8–11,13,16
Eye growth is thought to be regulated by retinal mechanisms
that act locally within the eye, producing a cascade of changes
that ultimately affect the structure of the sclera. Evidence for
the role of the retina in the control of eye growth comes from
studies involving optic nerve section17,18 (Wildsoet CF, et al.
IOVS 2010;51:ARVO E-Abstract 1737) or the pharmacologic
blockade of action potentials in the optic nerve.19,20 The results
of these studies indicate that gross regulation of ocular growth
appears not to require innervation from the brain. Further-
more, partial form deprivation induces myopic changes only in
the corresponding sector of the eye, a process difficult to
explain by a global centrally driven pathway7 (McFadden SA.
IOVS 2002;43:ARVO E-Abstract 189).
A retinal factor implicated in the control of eye growth is
the immediate early gene known as early growth response-1
(Egr-1). Egr-1 is a transcription factor that encodes a short-lived
nuclear protein with a zinc finger–binding domain. Its
expression is normally rapidly and transiently induced by
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extracellular stimuli. However, alterations in Egr-1 expression
in response to specific stimuli can be delayed by hours to
days, with its expression remaining altered for prolonged
periods.21 Egr-1 was first implicated in the modulation of eye
growth by the observation in chick retina that glucagonergic-
immunoreactive amacrine cells, positively labeled for the Egr-
1 peptide, show a bidirectional response to opposing growth
stimuli. Specifically, the percentage of these cells that
expresses both glucagon and Egr-1, relative to those express-
ing glucagon alone, decreases within 2 hours of FDM or LIM,
and increases within 2 hours of positive lens wear or removal
of diffusers from previously form-deprived eyes.22 Additional-
ly, in the avian retina, Egr-1 mRNA levels are rapidly
downregulated in response to FDM or LIM, and remain
downregulated during the entire period of increased ocular
growth.23 Following diffuser removal, Egr-1 mRNA levels
rapidly rise above that seen in form-deprived and control
untreated chick eyes.24 In response to positive lenses (which
cause growth suppression), earlier work by Simon et al.25
have indicated that Egr-1 mRNA levels are initially downreg-
ulated after 15 minutes ofþ7 D lens wear, but after 30 minutes
revert to a significant upregulation. Therefore, Egr-1 mRNA
levels generally show a bidirectional response in chicks. That
is, opposite changes occur in Egr-1 expression depending on
the direction of ocular growth: increased expression with
growth inhibition and decreased expression with growth
acceleration. The ability of pharmacologic agents, which
block the development of experimental myopia, to prevent
the downregulation in Egr-1 mRNA expression associated
with FDM24 and LIM23 in chicks suggests that decreases in Egr-
1 expression may be an obligatory precursor to myopic ocular
growth in the avian eye.
Evidence also suggests an association between changes in
ocular growth rates and alterations in Egr-1 expression in mice.
Egr-1 knockout mice show a relative myopic shift compared to
wild-type control animals.26 Egr-1 mRNA levels are also
reduced after 1 hour of diffuser wear in mice.27 However,
Egr-1 mRNA levels have not been directly measured in other
mammals or primates, or during lens wear, and it is unknown
whether upregulation in Egr-1 mRNA levels might occur
during inhibited ocular growth in species other than chicks.
In rhesus monkeys, the number of amacrine cells immuno-
reactive (IR) for Egr-1 is altered in response to visual
manipulation. Specifically, Egr-1 IR cell numbers decrease after
a brief period of diffuser wear (N¼ 3) and apparently increase
after a brief period of positive lens wear (N ¼ 3).28 These
changes are relative to fellow eyes wearing a plano lens, but
the mean number of cells IR for Egr-1 in the plano-wearing
fellow eyes differs significantly between these two groups. In
particular, Egr-1 cell numbers are significantly lower in the
plano eyes of animals wearing a positive lens, suggesting the
lens effect is instead manifested in the fellow eye.28 The
authors have proposed that this unexpected result may have
been due to the monkeys using the positive lens as a substitute
for accommodation. The consequences of this would be that
the positive lens-wearing eye would experience clear vision,
while the yoked fellow eye wearing a plano lens would
experience hyperopic defocus.28 If true, then the conclusion
from this monkey experiment is that Egr-1 immunoreactivity
decreases in the eyes experiencing growth from hyperopic
defocus or form deprivation, but the issue of a bidirectional
change in which Egr-1 is elevated with inhibited growth
remains unresolved.
The retinal cells that changed their immunoreactivity for
Egr-1 peptide in the rhesus monkey are a subpopulation of
gamma-aminobutyric acid (GABA) expressing amacrine cells
and a subpopulation of ON-bipolar cells.28 In chicken retina,
Egr-1 immunoreactivity has been reported to be associated
with short periods of defocus in glucagonergic amacrine cells,
but such cells have not been detected in mouse29 or monkey
retina.28 This suggests that species differences occur in the
localization of retinal Egr-1.
In the current study, we sought to directly measure Egr-1
mRNA transcript levels by using semi-quantitative real-time
reverse transcription polymerase chain reaction (qRT-PCR) in a
mammalian retina after animals experienced either positive or
negative defocus to induce opposite changes in ocular growth.
Specifically, changes in Egr-1 mRNA levels were measured in
retinas from young guinea pigs that had worn a negative lens
for a week (which induced myopic growth in response to
hyperopic defocus) or where the negative lens was worn for a
week and then removed for several days (which causes
recovery from myopia and inhibited ocular growth). In our
study, we used time points at which compensation for the
opposing growth responses were well advanced to avoid any
initial transient changes associated with subtle changes in light
or contrast, and to determine if longer-term changes in Egr-1
gene expression occur. Additionally, using immunohistochem-
istry, we determined the location of cells expressing Egr-1 in
the guinea pig retina.
MATERIALS AND METHODS
Animals and Housing
Approximately 50 guinea pigs (Cavia porcellus, pigmented,
tricolored) were bred at the University of Newcastle, New
South Wales, Australia, and housed with their mothers and
littermates in opaque plastic boxes (65 3 45 3 20 cm) with
stainless wire lids. Lighting was provided by three white light-
emitting diodes (1400 mA, Luxeon III Star; Philips Lumileds
Lighting Company, USA) evenly diffused through a Perspex
barrier located 20 cm above each box. The luminance in the
center of each holding box was 500 lux, and lights were on a
12/12 hour light/dark cycle (lights on at 10 AM). All
procedures were approved by the University of Newcastle
Animal Experimentation Ethics Committee and conformed to
the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research.
Experimental Treatments
Experiment 1: Measurement of Egr-1 Expression in
Retinas With Myopia or Inhibited Myopia. Animals within
a litter were randomly assigned to one of three groups: myopia
(N¼ 5); myopia recovery (N¼ 4); or normal untreated animals
(N¼ 5). Myopia was induced in the first two groups with a5
diopter (D) lens worn in front of one eye for 7 days (from 4–11
days of age). In the myopia group, the retinas of both eyes were
extracted at 11 days of age. In the myopia recovery group, the
5 D lens was removed at 11 days of age, and the eye
recovered from the induced myopia for the next 3 days,
followed by retinal extraction at 14 days of age. In the third
group, retinas were extracted at 11 days of age in normal
animals that did not wear a lens, to ascertain the normal
baseline. Refractive error was measured at 10 days of age in the
myopia and normal groups, or at both 10 and 13 days of age in
the myopia recovery group. Refractive error measurements
were undertaken the day before retinal extraction to ensure no
measurement factors interfered with the retinal state immedi-
ately before extraction. Lenses were initially applied or
removed 6 hours after lights were switched on (at 4 PM) and
retinal extractions were also done at 4 PM (i.e., in the middle of
their light cycle). Retinal tissue was analyzed for changes in
Egr-1 expression by using qRT-PCR.
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Experiment 2: Ocular Elongation After 7 Days of5 D
Lens Wear. To determine the amount that eyes grew with a5
D lens under the same timing conditions as in experiment 1,
eleven additional guinea pigs were raised with 5 D lenses
worn on one eye for 1 week from 4 days of age. At 10 days of
age, refractive error was measured as described in experiment
1. Immediately after the refractive error measurements,
animals were anesthetized with 1.5% isoflurane in oxygen
and the ocular length measured by using high-frequency
ultrasonography.
Experiment 3: Measurement of Diurnal/Circadian
Rhythm in Egr-1 Expression. Eighteen guinea pigs were
raised from 4 to 11 days of age. At 11 days of age, retinas were
extracted at 1, 5, 9, 13, 17, and 21 hours after the start of the
light cycle (six retinas per time point). Housing, lighting
conditions, retinal extraction, and measurement of Egr-1
expression were identical to those in experiment 1. Egr-1
expression was normalized against the mean value for b-actin
(reference control gene) at each time point.
Experiment 4: Immunohistochemical Localization of
Egr-1 in the Guinea Pig Retina. Approximately 12 retinas
were extracted from both adult and untreated 11-day-old
guinea pigs raised under the same lighting conditions as in
experiment 1. Egr-1 was localized in the extracted retinas using
immunohistochemistry.
Lenses and Application
Concave 5 D polymethylmethacrylate lenses (diameter and
optical zone of 14 mm, base curve of 8.5 mm; Gelflex, Perth,
Australia) were worn in front of one eye. They were attached
by using hook and loop fasteners (Birch Haberdashery and
Craft, Melbourne, Australia) as previously described.11 The
distance of the lens apex from the cornea (d) was approxi-
mately 5 mm; therefore, the effective power at the anterior
corneal surface (Fe) was 4.88 D (Fe ¼ F1ðd 3 FÞ). Lenses were
replaced with clean lenses daily, during which time the animals
were kept in the dark.
Ocular Measurements
Refractive error was measured with white light steak
retinoscopy 1 hour after cycloplegia had been induced (with
1–2 drops of cyclopentolate applied to the cornea for 1
minute). Measurements were taken in both the vertical and
horizontal meridian and averaged to give spherical equivalent
refractive error as previously described.30 In experiment 2,
internal ocular distances on axis were measured by using high-
frequency ultrasonography (20 MHz probe; Panametrics Model
176599 controller [Olympus, Notting Hill, Vic, Australia] and
100 MHz a/d Sonix 8100 sampling board [Springfield, VA,
USA]) as previously described.31 Ocular length was defined as
the distance from the front of the cornea to the back of the
sclera.
Retinal Extraction
After deep anesthesia (injection of 130 mg/kg of pentobarbi-
tone sodium into the heart in animals anesthetized with 1.5%
isoflurane in oxygen) the eyes were rapidly enucleated (within
approximately 1 minute to prevent degradation of the retinal
tissue). The cornea was removed by a circumference cut at the
limbus. The remaining posterior eye cup was floated in chilled
phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl,
11.3 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4; Sigma-Aldrich,
Sydney, Australia). The retina was separated from the
underlying RPE and choroid by inserting a finely tipped spatula
between the layers, allowing the retina to float to the surface of
the PBS solution, free of RPE or choroid. In general, retinal
tissue from light-adapted animals was readily collected free of
RPE. If fragments of RPE remained, they were lightly brushed
from the retina. For PCR analysis, each retina was placed in an
Eppendorf tube (North Ryde, NSW, Australia) and immediately
frozen by using liquid nitrogen and stored at 808C until
analyzed. For immunohistochemistry, the vitreous was re-
moved from the posterior eye cup and the whole eye cup was
fixed by immersion in 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4) for 2 hours at 48C. Eye cups were
washed once in PBS, cryoprotected in 30% sucrose in PBS,
embedded in O.C.T. compound (Tissue-Tek; Thermo Fisher
Scientific, Inc., Scoresby, Vic, Australia), and quickly frozen on
liquid nitrogen chilled ethanol (100%) and stored at808C until
analyzed.
Immunohistochemistry
Fifteen-micrometer-thick vertical retinal sections were cut from
the fixed embedded frozen eye cups using a cryostat (CM1850;
Leica Microsystems, North Ryde, Australia). Sections were cut in
the nasotemporal plane containing the optic nerve and were
thaw mounted onto gelatin-coated glass slides and air-dried
overnight. Sections were washed three times in PBS and
incubated overnight at 48C with rabbit monoclonal antibodies
to Egr-1 (1:500, 15F7, No. 4153, Entrez-Gene ID No. 1958, Swiss-
Prot Acc. No. P18146; Cell Signaling Technology, Inc., Danvers,
MA, USA). Slides were washed three times in PBS and then
incubated in secondary antibody (1:500, donkey anti-rabbit
secondary IgG, AffiniPure FITC 711-095-152; Jackson ImmunoR-
esearch Lab, Inc., ABACUS, Qld, Australia) in a humidified
chamber for 2 hours at room temperature. Negative controls
were run and some sections were double-labeled for GABA
(1:10,000, A0310; Sigma-Aldrich) or protein kinase C (1:100,
PKC mouse monoclonal IgG, MC5; Santa Cruz Biotech, Dallas,
TX, USA) and conjugated by secondary donkey anti-mouse IgG
(1:300, AffiniPure Cy3 715-165-150).
Real-Time Reverse Transcription–Polymerase
Chain Reaction (qRT-PCR)
The extraction of total RNA was undertaken by using a
combined Trizol/Qiagen RNeasy (Qiagen Pty Ltd, Chadstone
Centre, Vic, Australia) method as previously described.24,32
Purity of total RNA was checked by using gel electrophoresis
and a bioanalyzer, and quantified by using a nanodrop
spectrophotometer. Two micrograms of each sample were
reverse-transcribed to first-strand cDNA by using a SuperScript
VILO cDNA Synthesis Kit (Invitrogen, Mulgrave, Victoria,
Australia). As Egr-1 has not been annotated in the guinea pig,
primers were designed to detect conserved regions (high
TABLE 1. Gene-Specific RT-PCR Primer Information
Gene Product GenBank Acc. Forward Primer (50-30) Reverse Primer (50-30) Efficiency Product Size, bp
Egr-1 - GCACCCAACAGTGGCAACAC ACTGCTGTCGTTGGATGGCA 1.91 180
b-Actin NM_001172909.1 CACCAGGGAGTCATGGTAGG GGTGTGGTGCCAGATCTTCT 1.86 150
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homology) across rats (closest phylogenetic relative), mice,
and humans (Table 1). Product specificity was validated
through melt curve analysis, gel electrophoresis, and automat-
ed sequencing. Primer efficiency (E) was determined for Egr-1
and the reference gene of b-actin (actb, Sigma-Aldrich) from
the slope of the curve generated through a cDNA dilution
series, by using the formula E ¼ 10(1/slope).
All reactions were performed on a RotorGene 3000 qRT-PCR
cycler (Corbett Life Science [Qiagen], Chadstone Centre,
Victoria, Australia). Cycling conditions included an initial
denaturing phase of 958C for 5 minutes, followed by 35 cycles
of denaturation at 958C for 25 seconds, annealing at 608C for 15
seconds, and extension at 728C for 20 seconds. Repeated takeoff
values and sample amplification values obtained by the
RotorGene v6.0 software were transferred into a custom-built
Microsoft Excel (Microsoft Pty Ltd., North Ryde, NSW, Australia)
spreadsheet.
Sequencing of Egr-1 mRNA PCR Fragments
For sequencing analysis, PCR products were purified, cleaned,
and prepared by using a BigDye Terminator v3.1 Cycle
Sequencing Kit, following the manufacturer’s protocol (Ap-
plied Biosystems, Mulgrave, Victoria, Australia). All sequencing
reactions were undertaken by a sequencing unit core facility
(Biomedical Resource Facility at the Australian National
University) by using 5 ng of starting template and 3.2 pmol
of forward primer. Annotation of the PCR fragment was
determined from the analysis of four separate retinal PCR
samples, with each separate sample replicated/sequenced five
times. Egr-1 sequence alignment and phylogenetic tree
reconstruction from the sequence relationships were under-
taken in Clustal W 2.1 (http://www.genome.jp/tools/clustalw/;
provided in the public domain by Kyoto University Bioinfor-
matics Center). Phylogenetic tree reconstruction was done
against rat (NM_012551.2), mouse (NM_007913.5), human
(NM_001964.2), chimpanzee (XM_517958.2), and rhesus
monkey (XM_001107731.2).
Statistical Analysis
Results are presented as the mean 6 standard error of the
mean. The difference in refractive error between the lens-
wearing and fellow contralateral control eye was calculated for
each animal and the mean difference is referred to as the
‘‘relative’’ myopia. For retinal Egr-1 mRNA levels, the mean
normalized expression (MNE) of the target gene was calculated
separately for each condition (treated, fellow contralateral
control, and age-matched untreated control retinal tissue) as
previously described.23,33 The MNE was calculated from the
efficiency (E) of the target gene to the power of its average
threshold cycle (Ct) value (ECt, target), divided by the
efficiency (E) of the reference gene (b-actin) to the power of
its average Ct value (ECt, reference).33 Statistical differences
between the two eyes were based on matched pairs t-tests.
Comparisons between treated, contralateral, and age- and litter-
matched untreated eyes were based on repeated measures one-
way ANOVA followed by Holm-Sidak comparisons. Compari-
sons between different times in experiment 3 were based on
one-way ANOVA followed by Holm-Sidak comparisons. Statis-
tical analysis used JMP 7 (SAS, Cary, NC, USA) and Sigma-
PlotV11 (Systat Software, Inc., San Jose, CA, USA).
RESULTS
Changes in Refraction and Ocular Length
Animals wearing5 D lenses for 7 days in experiments 1 and 2
(N ¼ 20) developed 4.84 6 0.62 D of relative myopia (t19 ¼
9.4, P < 0.0001), compensating for the 4.8 D of imposed
effective hyperopic defocus difference between the eyes. The
eyes wearing the5 D lens on average developed0.99 6 0.69
D of myopia, while the fellow eyes remained relatively
hyperopic (þ3.86 6 0.35 D), the latter expected for young
animals of this age as complete emmetropization takes
approximately 30 days.30
In experiment 1, the average relative myopia induced by 7
days of 5 D lens wear was 5.35 6 0.78 D (N ¼ 9). The
biometric data for each subset of animals in each experiment
are shown in Table 2. In the subset of animals in experiment 1
randomly assigned to the myopia group, the lens-wearing eyes
became myopic in every animal (Fig. 1A; Table 2) and the
relative myopia was high (7.39 6 0.73 D, t4 ¼ 10.4, P <
0.001). In the myopia recovery group, the relative myopia
before lens removal was 3.76 6 0.17 D (Table 2), which
regressed during the 3 days of recovery in each animal (to an
average difference between the fellow and recovered eye of
0.53 6 1.15 D, Fig. 1B). The average relative recovery
calculated across individual animals (change in5 D eye minus
the change in the fellow eye) was a gain ofþ2.90 6 1.07 D of
hyperopia. If the change in refractive error was linear over
these short time periods (which is consistent with our
unpublished observations), then the myopia group developed
1.06 diopters per day of relative myopia, while the recovery
group developedþ0.97 diopters per day of relative hyperopia.
Normal untreated animals remained hyperopic (Table 2) and
their refractive error did not differ either between the two eyes
(t4¼0.53, P¼ 0.63, N¼ 5) or relative to fellow contralateral
control eyes (Fig. 1).
In experiment 2, animals developed 4.19 6 0.62 D of
relative myopia after 7 days of 5 D lens wear (t10 ¼ 6.8, P <
0.001, Fig. 2A) and a significant increase in ocular length
(difference between the eyes of 147 6 48 lm, t10 ¼ 3.1, P <
0.001, Fig. 2B). These changes were accompanied by a
significant increase in the depths of the anterior chamber
and the vitreous chamber, and a slightly thicker lens relative to
fellow contralateral control eyes (difference between the eyes
of 85 6 36 lm, P¼0.042, 45 6 12 lm, P¼0.005, and 24 6 11
lm, P¼ 0.047, respectively). The difference in refractive error
was correlated with the difference in ocular length (r2¼ 0.82,
TABLE 2. Mean RE in Eyes Analyzed for Egr-1 (From Experiment 1),
and Mean RE and Ocular Length Data From Experiment 2
Eye
RE Day 10, D RE Day 13, D
Mean SEM Mean SEM
Experiment 1
Myopia, N ¼ 5 Fellow 3.72 0.48




Fellow 4.05 1.29 3.58 0.31
5 D 0.62 1.40 3.05 1.42
Difference 3.43 0.42 0.53 1.15
Untreated, N ¼ 5 Left 4.12 0.18
Right 4.79 1.22
Difference 0.68 1.28
Experiment 2 OL (MM)
Myopia, N ¼ 11 Fellow 3.85 0.45 7.935 0.035
5 D 0.34 0.87 8.083 0.064
Difference 4.19 0.62 0.147 0.048
RE, refractive error; SEM, standard error of the mean; OL, ocular
length.
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F1,10 ¼ 41.3, P < 0.001). On average, eyes developed 1 D of
refractive change for every 30 lm in elongation, which is
consistent with that predicted from the model eye for the
guinea pig.30
Changes in Egr-1 Expression During the 24-Hour
Light/Dark Cycle
Retinal Egr-1 mRNA levels showed a statistically significant
variation over the light/dark cycle (F5,32 ¼ 7.7, P < 0.01, Fig.
3). This variation was due to elevated levels in the middle of
the day and reduced levels in the middle of the night (see Fig.
3). This suggests that Egr-1 expression in the guinea pig retina
may have a diurnal and/or circadian rhythm. Therefore, for
consistency, all samples for the following experiments were
collected at 4 PM, 6 hours after lights were switched on.
Retinal Egr-1 Expression in Response to Minus
Lens Wear and Recovery From Myopia
Seven days of negative lens wear (5 D) significantly reduced
retinal Egr-1 mRNA levels as compared to levels observed in
fellow contralateral control eyes (0.48 6 0.06 vs. 1.01 6 0.25
MNE, respectively; 51% 6 10% reduction; Holm-Sidak t¼3.7; P
¼ 0.019) and those observed in age-matched untreated control
eyes (0.48 6 0.06 vs. 1.00 6 0.18 MNE, respectively; 47% 6
6% reduction; Holm-Sidak t¼3.6; P¼0.015; Fig. 4A). Following
7 days of negative lens wear, the spectacle lens was removed to
initiate recovery. Three days after lens removal, a significant
upregulation in retinal Egr-1 mRNA levels occurred in the
recovering eye relative to that seen in the fellow contralateral
control eyes (2.13 6 0.16 vs. 1.06 6 0.16 MNE, respectively;
212% 6 28% increase; Holm-Sidak t¼ 8.8; P < 0.001; Fig. 4B)
and that observed in age-matched untreated control eyes (2.13
6 0.16 vs. 1.00 6 0.21 MNE, respectively; 234% 6 39%
increase; Holm-Sidak t ¼ 9.3; P < 0.001; Fig. 3B).
Egr-1 Immunoreactivity in Untreated Guinea Pig
Retinas
Intense labeling for Egr-1 occurred in cell somas located in the
inner nuclear layer (INL; Figs. 5A, 5B, 6B) and the ganglion cell
layer (GCL; Figs. 5B, 6A, 6B). The labeled cells in the INL had
somas approximately 6 to 8 lm in diameter, while those in the
GCL were larger (>10 lm) (see Fig. 6B for typical compari-
sons). Light labeling for Egr-1 was also observed within
processes that extended vertically through the retina from
FIGURE 2. Ocular changes in animals wearing a5 D lens on one eye
for 7 days in experiment 2. (A) Mean refractive error (mean spherical
equivalent) in the lens-wearing eyes and fellow contralateral control
eyes. (B) Ocular length (from ultrasonography) in the lens-wearing
eyes and fellow contralateral control eyes. ***P < 0.001 from matched
pair’s t-test.
FIGURE 3. Retinal Egr-1 mRNA levels at 4-hour intervals during a 24-
hour light/dark cycle in untreated animals. Gray area indicates the
night period. N ¼ 6 per time point. Egr-1 mRNA levels were lower in
the middle of the night than the middle of the day. Holm-Sidak
comparisons are shown where ***P < 0.001, **P < 0.001, *P < 0.05.
FIGURE 1. Mean refractive error (mean spherical equivalent) from eyes analyzed for Egr-1 mRNA expression in experiment 1. (A) Mean refractive
error in5 D monocular lens-wearing eyes and fellow contralateral control eyes after 7 days of treatment and in normal eyes in untreated animals
from the same litters as experimental animals (F2,14¼36.1, P < 0.001). (B) Mean refractive error in eyes 3 days after removal of the5 D monocular
lens, following 7 days of lens treatment, compared to that in fellow contralateral control eyes and litter-matched normal untreated eyes (F2,11¼ 0.6,
P ¼ 0.58). Holm-Sidak comparisons after one-way ANOVA are shown where ***P < 0.001.
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the photoreceptor (PR) layer to the GCL. These processes were
most visible within the inner retina (Fig. 5B, horizontal
arrows).
Immunoreactivity to PKC (a, b, c) was also present in these
long processes (Figs. 5C, 5D), which double-labeled for both
PKC and Egr-1 (Fig. 5F, horizontal arrows). PKC (a, b, c)
immunoreactivity could be traced from these processes into
end-foot–like structures in the GCL (Figs. 5C, 5D), consistent
with the morphology of Müller cells. PKC (a, b, c) immuno-
reactivity was also present in the periphery of the somas of
small cells in the INL and their processes. These small PKC-
labeled cells were located in the bipolar cell layer, and their
morphology was consistent with bipolar cells (Figs. 5C, 5D; red
arrows). It has previously been observed that PKC-a labels rod
ON-bipolar cells in many species, including guinea pigs.34–36
The globular terminals of these bipolar-like cells were also
intensely labeled for PKC (a, b, c) (Figs. 5C, 5D), consistent
with axon terminals of rod ON-bipolar cells.34 We did not
observe Egr-1 labeling of either the somas or terminals of these
PKC-labeled small cells (Figs. 5E, 5F). Their terminals were
located in the ON strata of the inner plexiform layer (IPL), close
to cell somas in the GCL (Fig. 5I). Some, but not all, of these
latter somas in the GCL (approximately 20–25 cells per retinal
section) were also IR for Egr-1 (Figs. 5F, 5J, 5K; circled).
Gamma-aminobutyric acid immunoreactivity was detected
in cell somas in the inner sublayer of the INL where amacrine
cell bodies are found and in the periphery of somas in the GCL
(Figs. 6C, 6D). Amacrine cells that labeled for Egr-1, but not for
GABA, were also observed within the INL (see example in Fig.
6F). However, some of the cells that labeled for Egr-1 in the
GCL (Figs. 6A, 6B) also double-labeled for GABA on the edge of
their somas, although not all did (Figs. 6E, 6F). In double-
labeled sections, approximately half of the somas in the GCL
that labeled for Egr-1 also labeled for GABA. Incubation with
mouse (Fig. 5G) or rabbit (Fig. 5H) secondary antibodies only
(negative controls) showed weak autofluorescence and no cell
labelling.
Sequencing of Egr-1 mRNA PCR Fragments From
Guinea Pig Retina
Sequence analysis of the PCR fragments obtained from guinea
pig retinal samples showed an expected fragment size of 180
bp (Fig. 7). The guinea pig Egr-1 mRNA fragment showed
significant homology to its closest phylogenetic relatives in the
rodent family, namely, the rat (86%) and mouse (85%) (Fig. 7).
Surprisingly, the guinea pig sequence showed even greater
homology with that of the Primate order, more specifically,
humans (89%), rhesus monkeys (89%), and chimpanzees
(89%). However, in the guinea pig, there was a 3-bp insert at
the 126-bp mark, making this fragment of the Egr-1 mRNA
sequence 180 bp long in rodents as compared to 177 bp long
in primates. Phylogenetic tree reconstruction from sequence
relationships (dendrogram), using Clustal W 2.1, indicated
three distinct groupings, namely, Rodentia (less the guinea
pig), Primates, and the guinea pig.
DISCUSSION
In different species studied (chicken, rhesus monkey, and
mice), manipulations that increase the rate of ocular growth
are associated with a rapid downregulation in Egr-1 mRNA
23–25,27 and/or peptide levels.22,28,37 In these studies, measures
were made within 30 minutes or hours after the introduction
of either a diffuser or a negative lens and in some cases,
unexpected changes were found in the contralateral control
eye. Changes in Egr-1 mRNA expression are also associated
with the onset and offset of light.27 However, changes in Egr-1
expression are not just associated with light transients, as
longer-term changes have been reported in the chick.23
Specifically, when tracking the response to 10 D lens wear
or diffuser wear over several days, it was found that an initial
rapid downregulation in Egr-1 RNA levels was sustained
throughout the period of increased growth. Furthermore, in
mice, downregulation in Egr-1 mRNA levels is much greater
after diffuser wear than after an equal light attenuation from
wearing neutral density filters.27 This suggests that the changes
in Egr-1 expression can be long-lasting, and not simply due to a
transient change in luminance associated with the application
of a lens or diffuser.
In the current study, a two-fold downregulation in Egr-1
mRNA levels occurred at a relatively advanced stage in the
response to negative lens wear in a mammalian retina. This is
consistent with the findings that changes in Egr-1 immuno-
reactivity are similar for different defocus exposure periods,
whether minutes or hours.22,28,37 It is curious that such a
robust suppression in the level of Egr-1 was seen after 7 days
of lens wear. By this time, the eyes had compensated for the
imposed defocus, so that little refractive error difference
remained between the two eyes (measured with the
FIGURE 4. Egr-1 mRNA levels in5 D lens-wearing eyes compared to fellow contralateral control and litter-matched normal untreated eyes. (A) Egr-
1 mRNA levels in myopic eyes induced by 7 days of5 D lens wear (F2,14¼ 8.7, P¼ 0.01). (B) Egr-1 mRNA levels during recovery from myopia 3
days after lens removal, following 7 days of5 D lens wear (F2,11¼ 55.0, P < 0.001). Holm-Sidak comparisons are shown where *P < 0.05, ***P <
0.001.
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spectacle lens in place). A similar result has been observed in
chicks, where Egr-1 mRNA levels do not return to control
values until 3 to 4 days after refractive compensation has
been achieved to a 10 D lens.23 However, the lack of a
refractive error difference does not imply that there is no
myopic response in progress. In guinea pigs, part of the
myopic response is contributed by changes in corneal power,
while the changes in vitreous elongation take approximately
12 days to fully compensate38 (Leotta AJ, et al. IOVS
2011;52:ARVO E-Abstract 6302). In chicks, choroidal thinning
also rapidly assists in eliminating some of the hyperopic
defocus before subsequent changes in eye growth occur.39
Therefore, changes in ocular growth may lag behind the
initiating defocus stimulus.
FIGURE 5. Immunoreactivity in vertical 15-lm sections from untreated guinea pig retinas showing Egr-1, PKC, and merged labeling. (A, B) Typical
immunoreactivity from Egr-1 antibody labeling (green). Intensely labeled somas for Egr-1 were present in the INL and GCL (white arrows). Light
labeling for Egr-1 was also observed in long processes that extended vertically through the retina (one example is indicated by the yellow arrows).
(C, D) Matching sections from (A, B) labeled with PKC (a, b, c) (red) showing labeling in bipolar cells (red arrows), in associated axons, and intense
labeling within globular terminals in the inner layer of the IPL. Cells similar to Müller cells were also weakly labeled (example processes are
indicated by the horizontal yellow arrows). (E, F) Triple-labeled sections for Egr-1, PKC, and DAPI from the same sections shown in (A, C) and (B,
D), respectively. The only overlap between PKC and Egr-1 labeling was in the long processes that vertically spanned the retina (horizontal yellow
arrows). Close proximity of PKC-containing terminals to Egr-1–labeled somas in the GCL were also observed (see circled example in [F]). Boxed
area in (E) is enlarged in (I). (G, H) Incubation with secondary antibodies only (negative controls) showed weak autofluorescence and no cell
labeling. (I–K) Merged images triple-labeled for Egr-1 (green), PKC (red), and DAPI (blue), showing proximity of PKC terminals and Egr-1–labeled
cells in the GCL. PKC, protein kinase C; DAPI, 40,6-diamidino-2-phenylindole, a nuclear stain that binds strongly to A-T rich regions in DNA. Retinal
layers are defined as: PR, photoreceptor; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer;
and GCL, ganglion cell layer.
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The driving stimulus behind the Egr-1 downregulation
could be either the initial optical defocus or some unidentified
myopia-generating retinal growth signal. Interestingly, the
induction of genes within the immediate early gene class are
not necessarily rapid and transient, but can also be character-
ized by a delayed and persistent change in expression.21 In
mice, it has been shown that after controlling for the effect of
changes in retinal illumination associated with diffuser wear,
Egr-1 mRNA expression is downregulated by 32% in eyes
exposed to only 30 minutes of visual stimulation during form
deprivation, presumably a period too short to affect immediate
changes in ocular growth.27 Taken together, these results
suggest that retinal Egr-1 expression is modulated in response
to hyperopic defocus, which can lead to a relatively persistent
reduction in Egr-1 mRNA expression in different species,
independent of light-driven transient changes in Egr-1 expres-
sion.
When a diffuser or lens is removed after myopia is induced,
the eye inhibits its rate of ocular elongation and recovers from
the induced myopia.40 In chicks, Egr-1 mRNA levels are rapidly
increased during such a period24 and return to baseline levels
(Ashby RS, et al. IOVS 2007;48:ARVO E-Abstract 5932) once the
defocus is fully compensated.41 In the current study, we found
that Egr-1 mRNA expression doubled in the guinea pig retina
after 3 days of recovery from negative lens-induced myopia. In
guinea pigs, once a lens is removed after a week of 5 D
monocular lens wear, it takes a further 7 days for the eye to
fully recover back to normal.42 This recovery process is due to
growth inhibition in the enlarged myopic eye, which allows
the two eyes to again become equal in length.42 In the current
study, the relative myopia was 3.43 D before the recovery
period, and 3 days after lens removal, the relative myopia had
reduced to 0.53 D, demonstrating that substantial recovery
from myopia had taken place. Therefore, the observed
upregulation of Egr-1 was not confined to the initiation of
recovery, but may be sustained throughout the recovery
period.
The apparent bidirectional change in the expression of Egr-
1 mRNA levels, in response to opposing defocus stimuli in a
mammalian eye, suggests that Egr-1 could be a marker
associated with the direction of ocular growth. If true, we
might also expect to find an upregulation in Egr-1 expression
in animals wearing a positive lens, since it is well established
that the eye compensates to positive lens wear by inhibiting
ocular growth16 (see Ref. 42 for review). In agreement with
this, an early study has demonstrated that the peptide levels of
Egr-1 are elevated in response to 30 minutes and 2 hours ofþ7
D lens wear in chicks, although after 30 minutes, the
contralateral untreated eyes are also affected.22 Similarly,
retinal Egr-1 peptide levels appear to be upregulated in the
rhesus monkey in response to þ3 D lens wear28; however, as
explained in the introduction, this may be due to defocus
effects in the control eyes wearing plano lenses. A reversal in
Egr-1 expression with positive lens wear has not been
consistently observed at the RNA level in chicks. Egr-1 mRNA
expression in chicks wearing þ7 D lenses for 24 hours is
actually reduced by 2.6-fold (from microarray analysis of
FIGURE 6. Immunoreactivity in vertical 15-lm sections from untreated guinea pig retinas showing Egr-1, GABA, and merged labeling. (A, B) Retinas
labeled with Egr-1 antibody (green) showing typical immunoreactivity in cell bodies within the INL (downward arrow) and GCL (upward arrows).
(C, D) Retinas labeled with GABA antibody (red), showing typical immunoreactivity in assumed amacrine cells (downward red arrows) and cells in
the GCL (upward red arrows). The latter could be displaced GABAergic amacrine cells. (E, F) Merged sections showing triple-labeling for Egr-1
(green), GABA (red), and DAPI (blue) of the same sections shown in (A, C) and (B, D), respectively. Double-labeling for Egr-1 and GABA was
observed in some cells in the GCL (double upward arrows), but not all. Double-labeling was not observed within the amacrine cell sublayer of the
INL (see example in [F]). See Figure 5 caption for abbreviations.
FIGURE 7. Sequence alignment (Clustal W 2.1) between guinea pig,
rat, mouse, human, rhesus monkey, and chimpanzee for the Egr-1 gene
fragment investigated. Sections highlighted in gray indicate areas of the
annotated sequence of the guinea pig Egr-1 fragment that are
homologous with the other species.
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whole retina),43 and 2.1-fold (based on microarray and PCR
analysis of the INL where amacrine cells are located).44 This
may be due to saturated baseline levels, since tissues were
extracted early in the light cycle, and light onset normally
causes a significant upregulation in Egr-1 expression.27
Alternatively, it is possible that the direction of defocus was
not as expected in these chick studies, since significant
choroidal changes occur within a 24-hour cycle of positive
lens wear,39 and when the choroid is expanded, the defocus
from the positive lens is significantly reduced.45 These findings
do not argue against the changes observed at the peptide level
or the changes we find in eyes recovering from negative lens
wear, but do indicate that further work is required to resolve
these complexities. It is possible that these differences arise
from timing differences, yoking between the eyes, and/or
different mechanism(s) for eye growth inhibition in different
inhibitory paradigms (McFadden SA, et al. IOVS 2009;50:ARVO
E-Abstract 1620).
Diurnal Changes in Egr-1 Expression in the
Guinea Pig Retina
Egr-1 mRNA expression in the guinea pig retina displayed a
distinct diurnal cycle, with Egr-1 levels elevated in the middle
of the day and reduced in the middle of the night. Similarly, in
both chicks and mice, Egr-1 mRNA26 and peptide22,27 levels are
observed to be higher during the day than during the night,
with a distinct but transient spike in expression seen 0.5 to 1.0
hour following the onset of light, and in some cases, at the
cessation of light.27 As we did not collect samples within these
time windows, we do not know if similar transient spikes in
Egr-1 expression also occur in the guinea pig retina. In the
current study, we avoided transient light-induced changes in
Egr-1 expression by consistently extracting retinal tissue in the
middle of the day. Similarly, we also avoided any lens-induced
light transients (which may occur when a spectacle lens is
introduced or removed) by extracting retinas many days after
such events occurred.
Since vertebrate eyes normally grow more in the day than at
night,46,47 Egr-1 levels appear paradoxical, in that they are
aligned with normal growth rates (increased when growth is
maximal, and decreased when growth is minimal), but
inversely related to abnormal growth rates (decreased with
accelerated growth, and increased with inhibited growth). A
similar dissociation between diurnal growth modulation and
abnormal accelerated growth rates has also been observed for
dopamine46 and glucagon,23,48 which have both been postu-
lated to play a role in the suppression of myopic growth.49 It is
possible that this apparent dissociation arises from a complex
interaction related to the phase shift in ocular growth in eyes
with accelerated growth, as observed in myopic chick eyes
whose axial length rhythm is phase advanced relative to their
fellow control eyes.47
Immunolocalization of Egr-1
At the protein level, we found that Egr-1 immunoreactivity was
present within the INL and GCL of the guinea pig retina. Cells
IR for Egr-1 within the INL were located in the inner margin of
this layer and could be either amacrine cells or displaced
ganglion cells. Although their soma size was smaller than that
typical for displaced ganglion cells in other species, such as
rabbit,50 there is significant variation between species with
regard to the size and distribution of displaced ganglion cells,
which have not been characterized in the guinea pig retina. In
monkeys, it has been concluded that the activated Egr-1 IR
somas in the amacrine layer are amacrine cells, because they
also double-label for GABA and GAD65. In the current study,
we did not observe double-labeling of Egr-1 and GABA within
the inner margin of the INL where amacrine cell somas are
normally located.
However, we did find a population of large Egr-1–labeled
cells in the GCL that also appeared to double-label for GABA. In
the guinea pig retina, GABA has been predominantly observed
within amacrine cells and, to a lesser extent, within the
GCL.51–53 From morphology and double-labeling, GABA
expression within the guinea pig GCL appears to be associated
with displaced amacrine cells.51–53 Since GABA has not been
noted to be present in ganglion cells of the guinea pig retina,
we tentatively conclude that the subpopulation of large cells in
the GCL that showed Egr-1 and GABA double-labeling
represent displaced amacrine cells. However, since sparse
GABA immunoreactivity has been observed within populations
of ganglion cells in both humans54 and rats,55 further detailed
studies are desirable. Similarly, it is unclear whether the cells
within the GCL that express Egr-1, but do not express GABA,
represent true ganglion cells owing to their large soma size, or
a second population of Egr-1 non-GABAergic displaced
amacrine cells.
Egr-1 labeling was also observed within long processes that
were double-labeled with a nonspecific PKC antibody. These
processes could be from bipolar cells and/or from Müller cells,
as both have been shown to label with PKC antibodies. In
guinea pigs, PKC-a labels rod ON-bipolar cells,34 while Müller
cells are known to contain PKC in guinea pigs56 as well as
being associated with a calcium-independent isoform, PKC-
d.57
In the monkey retina, defocus-induced changes in Egr-1
expression have also been reported in ON-bipolar cells.27
However, in the current study, Egr-1 labeling was not detected
in bipolar cell somas. In chicks, modulation of Egr-1
immunoreactivity in lightly labeled PKC-a bipolar cells (cone
ON-bipolar cells) is related to changes in light intensity rather
than defocus per se.22 In the guinea pig retina, we observed
PKC-labeled terminals, likely to be from rod ON-bipolar cells.34
These terminals appeared in close proximity to cells that
exhibited Egr-1 immunoreactivity. However, in the current
study, we did not have the resolution to identify synaptic
contacts. If direct synaptic contacts were found, suggesting a
possible interaction between rod ON-bipolar cells and cells IR
for Egr-1 in the GCL, it could implicate the ON pathway in the
control of ocular growth. In both monkeys and chicks, Egr-1
immunoreactivity is modulated in ON-bipolar cells in response
to defocus and/or light.22,28 However, at this stage we can only
conclude with certainty that Egr-1 labeling is commonly
detected in the retina of different species, and in mammals
and primates, may be associated with GABA-expressing
neurons.
Gene Sequencing
Comparison of the 180-bp fragment of the Egr-1 gene amplified
from the guinea pig retina with several other species, in which
the Egr-1 gene has been sequenced, showed surprising results.
The guinea pig sequence showed many similarities to its
closest phylogenetic relatives in the rodent family, namely, the
rat and mouse, such as a specific insert of three base pairs that
distinguished rodents from primates. However, the guinea pig
sequence also showed many similarities with primates
(humans, rhesus monkeys, and chimpanzees), specifically, in
regions where there was a distinct difference between
members of Primates and those of the Rodentia order.
Phylogenetic tree reconstruction based on sequence similari-
ties, using Clustal W 2.1, showed three distinct groupings,
namely, Rodentia, Primates, and the guinea pig. This was
surprising, as most genes that have been annotated in the
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guinea pig genome appear to be highly conserved between
guinea pigs and rats (closest phylogenetic relative that has
been sequenced), showing strong sequence homology. A
stronger homology with the Rodentia order may be observed
once the Egr-1 gene has been completely sequenced for the
guinea pig.
The Role of Related Genes in Ocular Growth
Intravitreal injection of an antisense oligonucleotide for c-fos, a
member of the IEG family of transcriptional regulators, induces
significant myopia in the guinea pig,58 while mRNA levels for
this IEG are downregulated in the mouse retina after 4 hours of
FDM.59 These findings suggest that perhaps a variety of
Immediate Early Genes (IEGs), such as Egr-1 and c-fos, have a
central role in the modulation of ocular growth. The genetic
locus containing the zinc finger pseudogene ZC3H11B, a
member of the CCCH-type zinc finger family to which Egr-1
belongs, is also strongly associated with axial length in
humans.60 This latter finding was based on three Genome
wide association studies conducted in Chinese and Malay
populations. Although the function of this pseudogene is
unknown, its coding counterpart (ZC3H11A) has been shown
to be downregulated in myopic mice eyes.60 Therefore, it is
possible that multiple members of the zinc finger family may be
involved in the regulatory pathways underlying eye growth. A
recent analysis of genomic DNA from leukocytes of 96 high
myopes in China has not detected any sequence variations in
the Egr-1 gene in this small population.61 Taken together with
the findings from animal studies, it suggests that any
association between Egr-1 activity and the development of
myopia in humans is not associated with a loss of function, due
to mutation, but rather may be due to a direct change in its
expression.
Conclusions
Egr-1 mRNA levels in a mammalian retina showed a bidirec-
tional persistent response to opposing defocus stimuli, being
downregulated after 7 days of negative lens wear (in which
hyperopic defocus stimulated growth) and upregulated during
recovery following negative lens removal (which suppressed
growth in response to myopic defocus). Since Egr-1 is located
in the retina, and its expression is a consistent bidirectional
marker of ocular growth, it may form an essential part of the
growth regulatory pathway(s) across species.
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